Medecine sciences : M/S | 2021

[Neonatal hearing screening].

 
 
 
 
 
 
 

Abstract


Neonatal hearing screening has been developped in a large number of countries. The rational to build such nationwide programs is robust. The prevalence of hearing impairment of various etiologies is high (1/1,000), diagnosis of hearing impairment in infants is uneasy and is made most of the time after the age of 18 months when treatment is less efficient and, last, appropriate test to screen for hearing impairment are available: Otoacoustic Emission and Auditory Evoked Potential. In France the screening is organised at the regional level. The organization of such a program is complexe. Midwifes and nurses should be trained to informed the parents and to perform the test. If the test is abnormal the infant will be oriented to a specialzed department of pediatrics for appropriate diagnosis and treatment.

Volume 37 5
Pages \n 519-527\n
DOI 10.1051/medsci/2021064
Language English
Journal Medecine sciences : M/S

Full Text